Comparison of 2 Different Regimens for Reactogenicity, Safety, and Immunogenicity of the Live Attenuated Oral Rotavirus Vaccine RIX4414 Coadministered with Oral Polio Vaccine in South African Infants | Zendy

A. Duncan Steele | Zendy; J. Reynders | Zendy; F. Scholtz | Zendy; P.K. Bos | Zendy; M. C. de Beer | Zendy; John Tumbo | Zendy; C.F. van der Merwe | Zendy; A. Delem | Zendy; Béatrice De Vos | Zendy

Open Access

Comparison of 2 Different Regimens for Reactogenicity, Safety, and Immunogenicity of the Live Attenuated Oral Rotavirus Vaccine RIX4414 Coadministered with Oral Polio Vaccine in South African Infants

Author(s) -

A. Duncan Steele,

J. Reynders,

F. Scholtz,

P.K. Bos,

M. C. de Beer,

John Tumbo,

C.F. van der Merwe,

A. Delem,

Béatrice De Vos

Publication year - 2010

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1086/653550

Subject(s) - reactogenicity , medicine , seroconversion , immunogenicity , rotavirus vaccine , placebo , poliomyelitis , vaccination , regimen , poliovirus , rotavirus , immunology , virology , antibody , virus , alternative medicine , pathology

A phase II, randomized, double-blind, placebo-controlled study was conducted in South Africa during 2003-2004 to evaluate the safety, reactogenicity, and immunogenicity of 2 regimens of the live attenuated oral human rotavirus vaccine RIX4414 when coadministered with the Expanded Program on Immunization childhood vaccines, including oral polio vaccine.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research